Serveur d'exploration sur Mozart

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Quantitative measurement of a new synthetic hetrazepine derivative, BN50730, in human plasma and urine by combined liquid chromatography—negative chemical ionization mass spectrometry using a particle beam interface

Identifieur interne : 000145 ( France/Analysis ); précédent : 000144; suivant : 000146

Quantitative measurement of a new synthetic hetrazepine derivative, BN50730, in human plasma and urine by combined liquid chromatography—negative chemical ionization mass spectrometry using a particle beam interface

Auteurs : J. Girault [France] ; J. M. Malgouyat [France] ; D. Longueville [France] ; G. Lecomte [France] ; M. Revaud [France] ; J. B. Fourtillan [France]

Source :

RBID : ISTEX:D806D841D51F0D75E711C4168F10297FAA4C1C3B

Abstract

A new simple and sensitive assay has been developed for the quantitative measurement of BN50730 at the picomole level in human plasma and urine. The drug and the internal standard (BN50765) were measured by combined liquid chromatography—negative chemical ionization mass spectrometry with methane as the reagent gas. A simple solid—liquid extraction procedure was used to isolate BN50730 from complex biological matrices. Mild operating conditions were required to assay the parent drug with a particle beam interface from Hewlett-Packard. The mass spectrometer was tuned to monitor the intense ion m/z 333, which was generated in the ion source by a dissociative capture process. This assay was performed with 1 ml of plasma or 0.1 ml of urine, and the quantification limit of the method was statistically calculated as 1 ng ml−1. The very low relative standard deviation and mean percentage of error calculated during the different within-day or between-day repeatability assays clearly demonstrate the ruggedness of the technique for the routine determination of BN50730 in the biological fluids. Some preliminary results on the pharmacokinetics of the drug are presented to illustrate the applicability of this new powerful LC—MS method.

Url:
DOI: 10.1016/0378-4347(94)00253-3


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

ISTEX:D806D841D51F0D75E711C4168F10297FAA4C1C3B

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Quantitative measurement of a new synthetic hetrazepine derivative, BN50730, in human plasma and urine by combined liquid chromatography—negative chemical ionization mass spectrometry using a particle beam interface</title>
<author>
<name sortKey="Girault, J" sort="Girault, J" uniqKey="Girault J" first="J." last="Girault">J. Girault</name>
</author>
<author>
<name sortKey="Malgouyat, J M" sort="Malgouyat, J M" uniqKey="Malgouyat J" first="J. M." last="Malgouyat">J. M. Malgouyat</name>
</author>
<author>
<name sortKey="Longueville, D" sort="Longueville, D" uniqKey="Longueville D" first="D." last="Longueville">D. Longueville</name>
</author>
<author>
<name sortKey="Lecomte, G" sort="Lecomte, G" uniqKey="Lecomte G" first="G." last="Lecomte">G. Lecomte</name>
</author>
<author>
<name sortKey="Revaud, M" sort="Revaud, M" uniqKey="Revaud M" first="M." last="Revaud">M. Revaud</name>
</author>
<author>
<name sortKey="Fourtillan, J B" sort="Fourtillan, J B" uniqKey="Fourtillan J" first="J. B." last="Fourtillan">J. B. Fourtillan</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:D806D841D51F0D75E711C4168F10297FAA4C1C3B</idno>
<date when="1994" year="1994">1994</date>
<idno type="doi">10.1016/0378-4347(94)00253-3</idno>
<idno type="url">https://api.istex.fr/document/D806D841D51F0D75E711C4168F10297FAA4C1C3B/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000276</idno>
<idno type="wicri:Area/Istex/Curation">000210</idno>
<idno type="wicri:Area/Istex/Checkpoint">003063</idno>
<idno type="wicri:doubleKey">0378-4347:1994:Girault J:quantitative:measurement:of</idno>
<idno type="wicri:Area/Main/Merge">003A48</idno>
<idno type="wicri:Area/Main/Curation">003939</idno>
<idno type="wicri:Area/Main/Exploration">003939</idno>
<idno type="wicri:Area/France/Extraction">000145</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">Quantitative measurement of a new synthetic hetrazepine derivative, BN50730, in human plasma and urine by combined liquid chromatography—negative chemical ionization mass spectrometry using a particle beam interface</title>
<author>
<name sortKey="Girault, J" sort="Girault, J" uniqKey="Girault J" first="J." last="Girault">J. Girault</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Cemaf Research Centre, 6 avenue Mozart, 86000 Poitiers</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Aquitaine-Limousin-Poitou-Charentes</region>
<region type="old region" nuts="2">Poitou-Charentes</region>
<settlement type="city">Poitiers</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Malgouyat, J M" sort="Malgouyat, J M" uniqKey="Malgouyat J" first="J. M." last="Malgouyat">J. M. Malgouyat</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Cemaf Research Centre, 6 avenue Mozart, 86000 Poitiers</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Aquitaine-Limousin-Poitou-Charentes</region>
<region type="old region" nuts="2">Poitou-Charentes</region>
<settlement type="city">Poitiers</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Longueville, D" sort="Longueville, D" uniqKey="Longueville D" first="D." last="Longueville">D. Longueville</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Cemaf Research Centre, 6 avenue Mozart, 86000 Poitiers</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Aquitaine-Limousin-Poitou-Charentes</region>
<region type="old region" nuts="2">Poitou-Charentes</region>
<settlement type="city">Poitiers</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Lecomte, G" sort="Lecomte, G" uniqKey="Lecomte G" first="G." last="Lecomte">G. Lecomte</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Cemaf Research Centre, 6 avenue Mozart, 86000 Poitiers</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Aquitaine-Limousin-Poitou-Charentes</region>
<region type="old region" nuts="2">Poitou-Charentes</region>
<settlement type="city">Poitiers</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Revaud, M" sort="Revaud, M" uniqKey="Revaud M" first="M." last="Revaud">M. Revaud</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Cemaf Research Centre, 6 avenue Mozart, 86000 Poitiers</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Aquitaine-Limousin-Poitou-Charentes</region>
<region type="old region" nuts="2">Poitou-Charentes</region>
<settlement type="city">Poitiers</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Fourtillan, J B" sort="Fourtillan, J B" uniqKey="Fourtillan J" first="J. B." last="Fourtillan">J. B. Fourtillan</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Cemaf Research Centre, 6 avenue Mozart, 86000 Poitiers</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Aquitaine-Limousin-Poitou-Charentes</region>
<region type="old region" nuts="2">Poitou-Charentes</region>
<settlement type="city">Poitiers</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Journal of Chromatography B: Biomedical Sciences and Applications</title>
<title level="j" type="abbrev">CHROLD</title>
<idno type="ISSN">0378-4347</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1994">1994</date>
<biblScope unit="volume">658</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="289">289</biblScope>
<biblScope unit="page" to="301">301</biblScope>
</imprint>
<idno type="ISSN">0378-4347</idno>
</series>
<idno type="istex">D806D841D51F0D75E711C4168F10297FAA4C1C3B</idno>
<idno type="DOI">10.1016/0378-4347(94)00253-3</idno>
<idno type="PII">0378-4347(94)00253-3</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0378-4347</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">A new simple and sensitive assay has been developed for the quantitative measurement of BN50730 at the picomole level in human plasma and urine. The drug and the internal standard (BN50765) were measured by combined liquid chromatography—negative chemical ionization mass spectrometry with methane as the reagent gas. A simple solid—liquid extraction procedure was used to isolate BN50730 from complex biological matrices. Mild operating conditions were required to assay the parent drug with a particle beam interface from Hewlett-Packard. The mass spectrometer was tuned to monitor the intense ion m/z 333, which was generated in the ion source by a dissociative capture process. This assay was performed with 1 ml of plasma or 0.1 ml of urine, and the quantification limit of the method was statistically calculated as 1 ng ml−1. The very low relative standard deviation and mean percentage of error calculated during the different within-day or between-day repeatability assays clearly demonstrate the ruggedness of the technique for the routine determination of BN50730 in the biological fluids. Some preliminary results on the pharmacokinetics of the drug are presented to illustrate the applicability of this new powerful LC—MS method.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>France</li>
</country>
<region>
<li>Aquitaine-Limousin-Poitou-Charentes</li>
<li>Poitou-Charentes</li>
</region>
<settlement>
<li>Poitiers</li>
</settlement>
</list>
<tree>
<country name="France">
<region name="Aquitaine-Limousin-Poitou-Charentes">
<name sortKey="Girault, J" sort="Girault, J" uniqKey="Girault J" first="J." last="Girault">J. Girault</name>
</region>
<name sortKey="Fourtillan, J B" sort="Fourtillan, J B" uniqKey="Fourtillan J" first="J. B." last="Fourtillan">J. B. Fourtillan</name>
<name sortKey="Lecomte, G" sort="Lecomte, G" uniqKey="Lecomte G" first="G." last="Lecomte">G. Lecomte</name>
<name sortKey="Longueville, D" sort="Longueville, D" uniqKey="Longueville D" first="D." last="Longueville">D. Longueville</name>
<name sortKey="Malgouyat, J M" sort="Malgouyat, J M" uniqKey="Malgouyat J" first="J. M." last="Malgouyat">J. M. Malgouyat</name>
<name sortKey="Revaud, M" sort="Revaud, M" uniqKey="Revaud M" first="M." last="Revaud">M. Revaud</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Musique/explor/MozartV1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000145 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000145 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Musique
   |area=    MozartV1
   |flux=    France
   |étape=   Analysis
   |type=    RBID
   |clé=     ISTEX:D806D841D51F0D75E711C4168F10297FAA4C1C3B
   |texte=   Quantitative measurement of a new synthetic hetrazepine derivative, BN50730, in human plasma and urine by combined liquid chromatography—negative chemical ionization mass spectrometry using a particle beam interface
}}

Wicri

This area was generated with Dilib version V0.6.20.
Data generation: Sun Apr 10 15:06:14 2016. Site generation: Tue Feb 7 15:40:35 2023